Trial Profile

first-in-human,single center, open-label study of Pharmacokinetics, Safety and Tolerability of the Iminosugar Sinbaglustat

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Jan 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sinbaglustat (Primary)
Indications CNS disorders; Lysosomal storage diseases; Renal impairment
Focus Adverse reactions; First in man; Pharmacokinetics

Most Recent Events

23 Dec 2020 Results published in the Journal of Clinical Pharmacology
08 Oct 2020 Status changed from recruiting to completed, according to an Idorsia Pharmaceuticals media release.
23 Sep 2020 Results presented at the 2020 American College of Clinical Pharmacology Annual Meeting

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com